+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

Extensive-Stage Small Cell Lung Cancer (ESCLC) - Pipeline Insight, 2025 - Product Thumbnail Image

Extensive-Stage Small Cell Lung Cancer (ESCLC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) - Pipeline Insight, 2025 - Product Thumbnail Image

PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Gliosarcoma - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Gliosarcoma - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Liver Diseases Treatment - Global Strategic Business Report - Product Thumbnail Image

Liver Diseases Treatment - Global Strategic Business Report

  • Report
  • August 2025
  • 194 Pages
  • Global
From
Pharmaceutical Drug Delivery - Global Strategic Business Report - Product Thumbnail Image

Pharmaceutical Drug Delivery - Global Strategic Business Report

  • Report
  • August 2025
  • 301 Pages
  • Global
From
Targeted Drug Delivery - Global Strategic Business Report - Product Thumbnail Image

Targeted Drug Delivery - Global Strategic Business Report

  • Report
  • August 2025
  • 168 Pages
  • Global
From
Acute Kidney Injury Treatment - Global Strategic Business Report - Product Thumbnail Image

Acute Kidney Injury Treatment - Global Strategic Business Report

  • Report
  • August 2025
  • 366 Pages
  • Global
From
Drug and Gene Delivery Devices - Global Strategic Business Report - Product Thumbnail Image

Drug and Gene Delivery Devices - Global Strategic Business Report

  • Report
  • August 2025
  • 278 Pages
  • Global
From
Primary Biliary Cholangitis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Primary Biliary Cholangitis Therapeutics - Global Strategic Business Report

  • Report
  • August 2025
  • 273 Pages
  • Global
From
Liver Metastases Treatment - Global Strategic Business Report - Product Thumbnail Image

Liver Metastases Treatment - Global Strategic Business Report

  • Report
  • August 2025
  • 370 Pages
  • Global
From
Schizophrenia Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

Schizophrenia Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • November 2023
  • 178 Pages
  • Global
From
Antibiotics Market by Product Type (Aminoglycosides, Beta Lactams, Macrolides), Route Of Administration (Oral, Parenteral, Topical), Type, Distribution Channel, Application, Spectrum - Global Forecast 2025-2030 - Product Thumbnail Image

Antibiotics Market by Product Type (Aminoglycosides, Beta Lactams, Macrolides), Route Of Administration (Oral, Parenteral, Topical), Type, Distribution Channel, Application, Spectrum - Global Forecast 2025-2030

  • Report
  • August 2025
  • 186 Pages
  • Global
From
Uveal Melanoma - Pipeline Insight, 2025 - Product Thumbnail Image

Uveal Melanoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Liver Cancer Drugs Market 2025-2029 - Product Thumbnail Image

Liver Cancer Drugs Market 2025-2029

  • Report
  • April 2025
  • 236 Pages
  • Global
From
Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 143 Pages
  • Global
From
Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1036 Pages
  • Global
From
Microsatellite Stable Colorectal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Microsatellite Stable Colorectal Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Pontine Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Pontine Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 138 Pages
  • Global
From
Anaplastic Astrocytoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Anaplastic Astrocytoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 106 Pages
  • Global
From
Neuroblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Neuroblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 308 Pages
  • Global
From
Loading Indicator